Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natsumi Watanabe

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Regenerative Therapy|June 28, 2019
Expedited approval system for regenerative medicine products - Is it unusual?Kazuo Yano, Natsumi Watanabe, Masayuki Yamato
Regenerative Therapy|June 28, 2019
PRP therapy classificationMasayuki Yamato, Natsumi Watanabe, Kazuo Yano
ACS Omega|September 2, 2024
Amantamide C, an Antitrypanosomal Linear Lipopeptide from a Marine <i>Okeania</i> sp. CyanobacteriumNatsumi Watanabe, Ghulam Jeelani, Tomoyoshi Nozaki, et al.
Regenerative Therapy|June 28, 2019
Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approvalYoji Jokura, Kazuo Yano, Natsumi Watanabe, et al.
Regenerative Therapy|June 28, 2019
Non-clinical assessment design of autologous chondrocyte implantation productsTaisuke Ikawa, Kazuo Yano, Natsumi Watanabe, et al.
The Journal of Physical Chemistry. A|April 21, 2026
Computational Analysis of Structural and Photophysical Properties of a 1,8-Naphthalimide Derivative in Aqueous SolutionNatsumi Watanabe, Masato Sumita, Hironori Izawa, et al.
Biomaterials|February 16, 2013
The regulation of allogeneic human cells and tissue products as biomaterialsKazuo Yano, Kenichiro Tsuyuki, Natsumi Watanabe, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product GlyberaNatsumi Watanabe, Kazuo Yano, Kenichiro Tsuyuki, et al.
Regenerative Therapy|June 28, 2019
Compassionate use of drugs and medical devices in the United States, the European Union and JapanKenichiro Tsuyuki, Kazuo Yano, Natsumi Watanabe, et al.
Regenerative Therapy|October 8, 2019
Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and JapanKazuo Yano, Natsumi Watanabe, Kenichiro Tsuyuki, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Regenerative Therapy|June 28, 2019
Expedited approval system for regenerative medicine products - Is it unusual?Kazuo Yano, Natsumi Watanabe, Masayuki Yamato
Regenerative Therapy|June 28, 2019
PRP therapy classificationMasayuki Yamato, Natsumi Watanabe, Kazuo Yano
ACS Omega|September 2, 2024
Amantamide C, an Antitrypanosomal Linear Lipopeptide from a Marine <i>Okeania</i> sp. CyanobacteriumNatsumi Watanabe, Ghulam Jeelani, Tomoyoshi Nozaki, et al.
Regenerative Therapy|June 28, 2019
Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approvalYoji Jokura, Kazuo Yano, Natsumi Watanabe, et al.
Regenerative Therapy|June 28, 2019
Non-clinical assessment design of autologous chondrocyte implantation productsTaisuke Ikawa, Kazuo Yano, Natsumi Watanabe, et al.
The Journal of Physical Chemistry. A|April 21, 2026
Computational Analysis of Structural and Photophysical Properties of a 1,8-Naphthalimide Derivative in Aqueous SolutionNatsumi Watanabe, Masato Sumita, Hironori Izawa, et al.
Biomaterials|February 16, 2013
The regulation of allogeneic human cells and tissue products as biomaterialsKazuo Yano, Kenichiro Tsuyuki, Natsumi Watanabe, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product GlyberaNatsumi Watanabe, Kazuo Yano, Kenichiro Tsuyuki, et al.
Regenerative Therapy|June 28, 2019
Compassionate use of drugs and medical devices in the United States, the European Union and JapanKenichiro Tsuyuki, Kazuo Yano, Natsumi Watanabe, et al.
Regenerative Therapy|October 8, 2019
Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and JapanKazuo Yano, Natsumi Watanabe, Kenichiro Tsuyuki, et al.
Pageof 6